Tag Archives: PATIENTS

FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older

FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older Print this page WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today that the U.S. Food and Drug Administration (FDA) has approved Katerzia (amlodipine)… Read More »

Asthma Patients Are Skipping Doses Due to High Cost, Finds Study

Representational Image (Photo Credits: PTI) Sydney, June 16: Out-of-pocket costs are preventing many people from taking vital asthma medication, says a new study, calling for urgent interventions to promote discussions between patients and doctors about the cost of medicines to treat asthma. The most commonly prescribed preventer treatments for asthma contain inhaled corticosteroids (ICS) which,… Read More »